003220 — Daewon Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Market Cap
KR₩292bn
Enterprise Value
KR₩443bn
Revenue
KR₩598bn

Annual balance sheet for Daewon Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10,521	54,820	47,006	30,030	46,108
Net Total Accounts Receivable
Net Total Receivables	42,312	54,595	66,847	73,387	77,929
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	117,276	180,377	207,284	209,293	257,570
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	157,252	166,674	158,912	160,092	208,378
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	335,214	429,580	453,550	507,998	583,389
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	56,017	102,076	128,146	182,690	200,776
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	121,276	210,281	202,603	241,799	308,104
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	213,938	219,299	250,947	266,199	275,285
Total Liabilities & Shareholders' Equity	335,214	429,580	453,550	507,998	583,389
Total Common Shares Outstanding